We should see NDA filing for Zolpidem by end of year. Could be a nice catalyst. I picked up shares on Friday at $0.31. Downside is limited. Upside could be dollars.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.